Ad is loading...
SCYX
Price
$1.20
Change
-$0.06 (-4.76%)
Updated
Nov 15 closing price
129 days until earnings call
SGIOY
Price
$6.81
Change
-$0.01 (-0.15%)
Updated
Nov 15 closing price
75 days until earnings call
Ad is loading...

SCYX vs SGIOY

Header iconSCYX vs SGIOY Comparison
Open Charts SCYX vs SGIOYBanner chart's image
SCYNEXIS
Price$1.20
Change-$0.06 (-4.76%)
Volume$223.93K
CapitalizationN/A
Shionogi & Co
Price$6.81
Change-$0.01 (-0.15%)
Volume$508.35K
CapitalizationN/A
SCYX vs SGIOY Comparison Chart
Loading...
SCYX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SGIOY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
SCYX vs. SGIOY commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCYX is a StrongSell and SGIOY is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (SCYX: $1.20 vs. SGIOY: $6.81)
Brand notoriety: SCYX and SGIOY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: SCYX: 153% vs. SGIOY: 390%
Market capitalization -- SCYX: $55.88M vs. SGIOY: $12.4B
SCYX [@Pharmaceuticals: Other] is valued at $55.88M. SGIOY’s [@Pharmaceuticals: Other] market capitalization is $12.4B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SCYX’s FA Score shows that 0 FA rating(s) are green whileSGIOY’s FA Score has 1 green FA rating(s).

  • SCYX’s FA Score: 0 green, 5 red.
  • SGIOY’s FA Score: 1 green, 4 red.
According to our system of comparison, SGIOY is a better buy in the long-term than SCYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SCYX’s TA Score shows that 3 TA indicator(s) are bullish while SGIOY’s TA Score has 3 bullish TA indicator(s).

  • SCYX’s TA Score: 3 bullish, 6 bearish.
  • SGIOY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, SGIOY is a better buy in the short-term than SCYX.

Price Growth

SCYX (@Pharmaceuticals: Other) experienced а -8.40% price change this week, while SGIOY (@Pharmaceuticals: Other) price change was -2.84% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Reported Earning Dates

SCYX is expected to report earnings on Mar 26, 2025.

SGIOY is expected to report earnings on Jan 31, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SGIOY($12.4B) has a higher market cap than SCYX($55.9M). SGIOY has higher P/E ratio than SCYX: SGIOY (9.62) vs SCYX (1.06). SGIOY YTD gains are higher at: -13.312 vs. SCYX (-46.188). SGIOY has higher annual earnings (EBITDA): 242B vs. SCYX (70.9M). SGIOY has more cash in the bank: 563B vs. SCYX (74.4M). SCYX has less debt than SGIOY: SCYX (15.1M) vs SGIOY (9.41B). SGIOY has higher revenues than SCYX: SGIOY (427B) vs SCYX (140M).
SCYXSGIOYSCYX / SGIOY
Capitalization55.9M12.4B0%
EBITDA70.9M242B0%
Gain YTD-46.188-13.312347%
P/E Ratio1.069.6211%
Revenue140M427B0%
Total Cash74.4M563B0%
Total Debt15.1M9.41B0%
FUNDAMENTALS RATINGS
SCYX vs SGIOY: Fundamental Ratings
SCYX
SGIOY
OUTLOOK RATING
1..100
5350
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9558
PRICE GROWTH RATING
1..100
9072
P/E GROWTH RATING
1..100
9983
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SGIOY's Valuation (29) in the null industry is in the same range as SCYX (42) in the Pharmaceuticals Other industry. This means that SGIOY’s stock grew similarly to SCYX’s over the last 12 months.

SGIOY's Profit vs Risk Rating (100) in the null industry is in the same range as SCYX (100) in the Pharmaceuticals Other industry. This means that SGIOY’s stock grew similarly to SCYX’s over the last 12 months.

SGIOY's SMR Rating (58) in the null industry is somewhat better than the same rating for SCYX (95) in the Pharmaceuticals Other industry. This means that SGIOY’s stock grew somewhat faster than SCYX’s over the last 12 months.

SGIOY's Price Growth Rating (72) in the null industry is in the same range as SCYX (90) in the Pharmaceuticals Other industry. This means that SGIOY’s stock grew similarly to SCYX’s over the last 12 months.

SGIOY's P/E Growth Rating (83) in the null industry is in the same range as SCYX (99) in the Pharmaceuticals Other industry. This means that SGIOY’s stock grew similarly to SCYX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SCYXSGIOY
RSI
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
57%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
50%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
63%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
71%
Advances
ODDS (%)
N/A
Bullish Trend 19 days ago
63%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 5 days ago
61%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
68%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
59%
View a ticker or compare two or three
Ad is loading...
SCYX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SGIOY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CELU2.460.21
+9.33%
Celularity
BLCO19.680.11
+0.56%
Bausch + Lomb Corp
SLB43.18-0.27
-0.62%
Schlumberger Limited
NTCT21.86-0.56
-2.50%
NetScout Systems
MYPS1.72-0.07
-3.91%
PLAYSTUDIOS

SCYX and

Correlation & Price change

A.I.dvisor tells us that SCYX and ITCI have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCYX and ITCI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCYX
1D Price
Change %
SCYX100%
-4.76%
ITCI - SCYX
29%
Poorly correlated
-4.80%
ACET - SCYX
27%
Poorly correlated
-9.82%
PAHC - SCYX
26%
Poorly correlated
-1.77%
ESPR - SCYX
26%
Poorly correlated
+0.95%
DVAX - SCYX
25%
Poorly correlated
-8.81%
More

SGIOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGIOY has been loosely correlated with TAK. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SGIOY jumps, then TAK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGIOY
1D Price
Change %
SGIOY100%
-0.13%
TAK - SGIOY
40%
Loosely correlated
+0.37%
ESAIY - SGIOY
36%
Loosely correlated
-5.26%
KMDA - SGIOY
27%
Poorly correlated
-0.85%
SCYX - SGIOY
23%
Poorly correlated
-4.76%
SUPN - SGIOY
22%
Poorly correlated
-1.69%
More